The long term objective of this proposal is to learn the role of cytoskeletal alterations in the degeneration of neurons in normal aged and Alzheimer disease (AD), a major public health problem in modern society with its rapidly increasing elderly population. AD is characterized clinically by progressive dementia, and histopathologically by an intraneuronal accumulation of masses of paired helical filaments (PHF), disrupting the normal cytoskeleton, and an extracellular deposition of Beta-amyloid in the brain. The presence of PHF correlates with dementia. The PHF are made up of abnormally hyperphosphorylated tau. Hyperphosphorylated tau also occurs in the nonpolymerized form in the neuronal cytoplasm and might be one of the earliest and most critical events contributing to the cytoskeletal pathology in AD. To understand the generation and catabolism of the unpolymerized hypephosphorylated tau (AD P-tau) and its interaction with the normal cytoskeleton, it is proposed to: 1. Determine by radioimmunoassay the relative levels of phosphorylation with site-specific antibodies and compare the agree of phosphorylation at defined sites within AD P-tau and between AD P-tau and PHF tau; 2. Study the interaction of AD P-tau with the microtubule system by determining the interaction kinetics between AD P-tau and normal tau and by analyzing the effect of AD P-tau in vitro on preformed microtubules and in vivo on the microtubule network of cultured cells; 3. Generate hyperphosphorylated tau-in cultured cells by treatment with phosphatase inhibitors and kinase simulators and compare the hyperphosphorylated tau with normal human tau and AD P-tau with respect to its polypeptide pattern and levels of phosphorylation sites, and 4. Study the rate of synthesis and turnover of normal and hyperphosphorylated tau in cultured radiolabeled cells and determine whether tau is degraded mostly by the lysosomal pathway and whether the hyperphosphorylation of tau makes it more resistant to degradation. Phosphorylation sites will be determined by radioimmuno- slot-blot assays. The interaction of AD P-tau with normal tau will be examined in vitro by an overlay radioimmuno assay, and in vivo by intracellular injections and immunocytochemistry. Cell culture models of hyperphosphorylated tau and processing of tau will be investigated by pulse chase studies and Western blots and immunocytochemist.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS018105-17S1
Application #
6094433
Study Section
Neurology A Study Section (NEUA)
Program Officer
Murphy, Diane
Project Start
1981-06-01
Project End
2002-06-30
Budget Start
1998-07-01
Budget End
2002-06-30
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Institute for Basic Research in Dev Disabil
Department
Type
DUNS #
167205090
City
Staten Island
State
NY
Country
United States
Zip Code
10314
Sengupta, Amitabha; Novak, Michal; Grundke-Iqbal, Inge et al. (2006) Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level. FEBS Lett 580:5925-33
Ruben, George C; Novak, Michal; Edwards, Patricia C et al. (2005) Alzheimer paired helical filaments (PHFs) studied by high-resolution TEM: what can vertical Pt-C replication tell us about the organization of the pronase-digested PHF core? Microsc Res Tech 67:196-209
Ruben, George C; Wang, Jian-Zhi; Iqbal, Khalid et al. (2005) Paired helical filaments (PHFs) are a family of single filament structures with a common helical turn period: negatively stained PHF imaged by TEM and measured before and after sonication, deglycosylation, and dephosphorylation. Microsc Res Tech 67:175-95
Haque, Niloufar; Gong, Cheng-Xin; Sengupta, Amitabha et al. (2004) Regulation of microtubule-associated proteins, protein kinases and protein phosphatases during differentiation of SY5Y cells. Brain Res Mol Brain Res 129:163-70
Tatebayashi, Yoshitaka; Haque, Niloufar; Tung, Yunn-Chyn et al. (2004) Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport. J Cell Sci 117:1653-63
Tatebayashi, Yoshitaka; Lee, Moon H; Li, Liang et al. (2003) The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. Acta Neuropathol (Berl) 105:225-32
Liu, F; Zaidi, T; Iqbal, K et al. (2002) Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience 115:829-37
Iqbal, Khalid; Grundke-Iqbal, Inge (2002) Neurofibrillary pathology leads to synaptic loss and not the other way around in Alzheimer disease. J Alzheimers Dis 4:235-8
Pei, Jin-Jing; Braak, Heiko; Gong, Cheng-Xin et al. (2002) Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Acta Neuropathol (Berl) 104:369-76
Pei, Jin-Jing; Braak, Heiko; An, Wen-Lin et al. (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res Mol Brain Res 109:45-55

Showing the most recent 10 out of 91 publications